HEADER LYASE 27-SEP-13 4C81 TITLE ISPF (PLASMODIUM FALCIPARUM) CDP COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: 2-C-METHYL-D-ERYTHRITOL 2,4-CYCLODIPHOSPHATE SYNTHASE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: MATURE PROTEIN (APICOPLAST-TARGETING SEQUENCE OMITTED), COMPND 5 RESIDUES 60-240; COMPND 6 SYNONYM: MECDP-SYNTHASE, MECPS, 2C-METHYL-D-ERYTHRITOL-2,4- COMPND 7 CYCLODIPHOSPHATE SYNTHASE; COMPND 8 EC: 4.6.1.12; COMPND 9 ENGINEERED: YES; COMPND 10 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PLASMODIUM FALCIPARUM; SOURCE 3 ORGANISM_TAXID: 36329; SOURCE 4 STRAIN: 3D7; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VARIANT: GOLD; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET15BTEV; SOURCE 10 OTHER_DETAILS: SYNTHETIC GENE KEYWDS LYASE EXPDTA X-RAY DIFFRACTION AUTHOR P.E.F.O'ROURKE,J.KALINOWSKA-TLUSCIK,P.K.FYFE,A.DAWSON,W.N.HUNTER REVDAT 5 20-DEC-23 4C81 1 REMARK LINK REVDAT 4 29-MAY-19 4C81 1 REMARK REVDAT 3 08-MAY-19 4C81 1 REMARK REVDAT 2 12-MAR-14 4C81 1 JRNL REVDAT 1 08-JAN-14 4C81 0 JRNL AUTH P.E.O ROURKE,J.KALINOWSKA-TLUSCIK,P.K.FYFE,A.DAWSON, JRNL AUTH 2 W.N.HUNTER JRNL TITL CRYSTAL STRUCTURES OF ISPF FROM PLASMODIUM FALCIPARUM AND JRNL TITL 2 BURKHOLDERIA CENOCEPACIA: COMPARISONS INFORM ANTIMICROBIAL JRNL TITL 3 DRUG TARGET ASSESSMENT. JRNL REF BMC STRUCT.BIOL. V. 14 1 2014 JRNL REFN ESSN 1472-6807 JRNL PMID 24410837 JRNL DOI 10.1186/1472-6807-14-1 REMARK 2 REMARK 2 RESOLUTION. 1.56 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0094 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.56 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 26.38 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 92.0 REMARK 3 NUMBER OF REFLECTIONS : 33786 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.145 REMARK 3 R VALUE (WORKING SET) : 0.144 REMARK 3 FREE R VALUE : 0.165 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1810 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.56 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.60 REMARK 3 REFLECTION IN BIN (WORKING SET) : 0 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 0.00 REMARK 3 BIN R VALUE (WORKING SET) : 0.0000 REMARK 3 BIN FREE R VALUE SET COUNT : 0 REMARK 3 BIN FREE R VALUE : 0.0000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1213 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 35 REMARK 3 SOLVENT ATOMS : 85 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 22.95 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.80000 REMARK 3 B22 (A**2) : 0.80000 REMARK 3 B33 (A**2) : -1.59000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.011 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.012 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.034 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 1.077 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.976 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.967 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 1332 ; 0.005 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 877 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 1815 ; 0.967 ; 2.036 REMARK 3 BOND ANGLES OTHERS (DEGREES): 2159 ; 0.761 ; 3.003 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 167 ; 4.905 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 50 ;41.391 ;25.800 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 252 ;11.696 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 4 ;13.944 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 225 ; 0.059 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1400 ; 0.002 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 224 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 798 ; 5.638 ; 5.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 332 ; 1.569 ; 5.000 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1304 ; 7.993 ;10.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 534 ;13.774 ;15.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 506 ;18.907 ;20.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TWIN DETAILS REMARK 3 NUMBER OF TWIN DOMAINS : 2 REMARK 3 TWIN DOMAIN : 1 REMARK 3 TWIN OPERATOR : H, K, L REMARK 3 TWIN FRACTION : 0.558 REMARK 3 TWIN DOMAIN : 2 REMARK 3 TWIN OPERATOR : K, H, -L REMARK 3 TWIN FRACTION : 0.442 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. U VALUES REFINED INDIVIDUALLY. RESIDUES 83-97 AND 144- REMARK 3 151 ARE DISORDERED. REMARK 4 REMARK 4 4C81 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 27-SEP-13. REMARK 100 THE DEPOSITION ID IS D_1290058506. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-MAY-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID29 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.98410 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 35607 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.600 REMARK 200 RESOLUTION RANGE LOW (A) : 41.630 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 200 DATA REDUNDANCY : 5.100 REMARK 200 R MERGE (I) : 0.09000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 11.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.69 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.3 REMARK 200 DATA REDUNDANCY IN SHELL : 3.30 REMARK 200 R MERGE FOR SHELL (I) : 0.42000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 1GX1 REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 63.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.40 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN WAS CRYSTALLISED BY HANGING REMARK 280 -DROP VAPOUR DIFFUSION. PFISPF SAMPLE IN 100 MM KCL, 100 MM L- REMARK 280 ARGININE, 2 MM MGCL2, 50 MM CHES, PH 9.5; WAS CONCENTRATED TO 6 REMARK 280 MG/ML, AND HAD CDP DISODIUM SALT ADDED (2 MM FINAL CONCENTRATION) REMARK 280 . CRYSTALS WERE OBTAINED BY MIXING 2 MICROLITES OF PROTEIN WITH REMARK 280 2 MICROLITRES OF RESERVOIR SOLUTION AT 20 DEGREES C. RESERVOIR REMARK 280 SOLUTION: 1.8-2.5 M (NH4)2SO4, 5MM ZNCL2, 100 MM BIS-TRIS, PH REMARK 280 5.5. SATURATED SUCROSE WAS USED AS A CRYO-PROTECTANT DURING REMARK 280 COLLECTION., VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: H 3 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z REMARK 290 3555 -X+Y,-X,Z REMARK 290 4555 X+2/3,Y+1/3,Z+1/3 REMARK 290 5555 -Y+2/3,X-Y+1/3,Z+1/3 REMARK 290 6555 -X+Y+2/3,-X+1/3,Z+1/3 REMARK 290 7555 X+1/3,Y+2/3,Z+2/3 REMARK 290 8555 -Y+1/3,X-Y+2/3,Z+2/3 REMARK 290 9555 -X+Y+1/3,-X+2/3,Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 42.43200 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 24.49813 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 33.67700 REMARK 290 SMTRY1 5 -0.500000 -0.866025 0.000000 42.43200 REMARK 290 SMTRY2 5 0.866025 -0.500000 0.000000 24.49813 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 33.67700 REMARK 290 SMTRY1 6 -0.500000 0.866025 0.000000 42.43200 REMARK 290 SMTRY2 6 -0.866025 -0.500000 0.000000 24.49813 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 33.67700 REMARK 290 SMTRY1 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 48.99625 REMARK 290 SMTRY3 7 0.000000 0.000000 1.000000 67.35400 REMARK 290 SMTRY1 8 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 8 0.866025 -0.500000 0.000000 48.99625 REMARK 290 SMTRY3 8 0.000000 0.000000 1.000000 67.35400 REMARK 290 SMTRY1 9 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 9 -0.866025 -0.500000 0.000000 48.99625 REMARK 290 SMTRY3 9 0.000000 0.000000 1.000000 67.35400 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 12280 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18180 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -350.2 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 -84.86400 REMARK 350 BIOMT2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 3 -0.500000 0.866025 0.000000 -42.43200 REMARK 350 BIOMT2 3 -0.866025 -0.500000 0.000000 -73.49438 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 S SO4 A1247 LIES ON A SPECIAL POSITION. REMARK 375 O4 SO4 A1247 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 57 REMARK 465 HIS A 58 REMARK 465 MET A 59 REMARK 465 TYR A 82 REMARK 465 ASN A 83 REMARK 465 THR A 84 REMARK 465 TYR A 85 REMARK 465 ALA A 86 REMARK 465 ASN A 87 REMARK 465 ASN A 88 REMARK 465 ASP A 89 REMARK 465 PHE A 90 REMARK 465 ASN A 91 REMARK 465 LYS A 92 REMARK 465 ASN A 93 REMARK 465 GLU A 94 REMARK 465 GLN A 95 REMARK 465 SER A 96 REMARK 465 PHE A 97 REMARK 465 ASP A 144 REMARK 465 LYS A 145 REMARK 465 ASP A 146 REMARK 465 GLU A 147 REMARK 465 LYS A 148 REMARK 465 ASN A 149 REMARK 465 LYS A 150 REMARK 465 ASN A 151 REMARK 465 SER A 240 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 79 -156.74 -101.31 REMARK 500 LEU A 136 -125.44 -22.51 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A1240 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 71 OD2 REMARK 620 2 HIS A 73 NE2 99.8 REMARK 620 3 HIS A 123 ND1 102.1 114.8 REMARK 620 4 HOH A2009 O 111.2 123.8 103.2 REMARK 620 N 1 2 3 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A1241 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 215 NE2 REMARK 620 2 GLU A 228 OE1 123.2 REMARK 620 3 CL A1244 CL 103.6 110.7 REMARK 620 4 CL A1246 CL 107.2 97.5 115.1 REMARK 620 N 1 2 3 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 1240 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 1241 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CDP A 1242 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 1244 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 1245 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 1246 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1247 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4C82 RELATED DB: PDB REMARK 900 ISPF (PLASMODIUM FALCIPARUM) UNLIGANDED STRUCTURE REMARK 900 RELATED ID: 4C8E RELATED DB: PDB REMARK 900 ISPF (BURKHOLDERIA CENOCEPACIA) 2CMP COMPLEX REMARK 900 RELATED ID: 4C8G RELATED DB: PDB REMARK 900 ISPF (BURKHOLDERIA CENOCEPACIA) CMP COMPLEX REMARK 900 RELATED ID: 4C8I RELATED DB: PDB REMARK 900 ISPF (BURKHOLDERIA CENOCEPACIA) CITRATE COMPLEX REMARK 999 REMARK 999 SEQUENCE REMARK 999 RESIDUES 1-59, A PREDICTED APICOPLAST TARGETING SEQUENCE, REMARK 999 HAVE BEEN OMITTED FROM THE CONSTRUCT USED TO PREPARE REMARK 999 PROTEIN FOR CRYSTALLISATION. DBREF 4C81 A 60 240 UNP P62368 ISPF_PLAF7 60 240 SEQADV 4C81 GLY A 57 UNP P62368 EXPRESSION TAG SEQADV 4C81 HIS A 58 UNP P62368 EXPRESSION TAG SEQADV 4C81 MET A 59 UNP P62368 EXPRESSION TAG SEQADV 4C81 SER A 60 UNP P62368 CYS 60 ENGINEERED MUTATION SEQRES 1 A 184 GLY HIS MET SER TYR ASN GLY ILE ARG ILE GLY GLN GLY SEQRES 2 A 184 TYR ASP ILE HIS LYS ILE LYS VAL LEU ASP GLU GLU TYR SEQRES 3 A 184 ASN THR TYR ALA ASN ASN ASP PHE ASN LYS ASN GLU GLN SEQRES 4 A 184 SER PHE LYS THR LEU THR LEU GLY GLY VAL LYS ILE ASN SEQRES 5 A 184 ASN VAL LEU VAL LEU SER HIS SER ASP GLY ASP ILE ILE SEQRES 6 A 184 TYR HIS SER ILE VAL ASP SER ILE LEU GLY ALA LEU GLY SEQRES 7 A 184 SER LEU ASP ILE GLY THR LEU PHE PRO ASP LYS ASP GLU SEQRES 8 A 184 LYS ASN LYS ASN LYS ASN SER ALA ILE PHE LEU ARG TYR SEQRES 9 A 184 ALA ARG LEU LEU ILE TYR LYS LYS ASN TYR ASP ILE GLY SEQRES 10 A 184 ASN VAL ASP ILE ASN VAL ILE ALA GLN VAL PRO LYS ILE SEQRES 11 A 184 SER ASN ILE ARG LYS ASN ILE ILE LYS ASN ILE SER THR SEQRES 12 A 184 VAL LEU ASN ILE ASP GLU SER GLN ILE SER VAL LYS GLY SEQRES 13 A 184 LYS THR HIS GLU LYS LEU GLY VAL ILE GLY GLU LYS LYS SEQRES 14 A 184 ALA ILE GLU CYS PHE ALA ASN ILE LEU LEU ILE PRO LYS SEQRES 15 A 184 ASN SER HET ZN A1240 1 HET ZN A1241 1 HET CDP A1242 50 HET CL A1244 1 HET CL A1245 1 HET CL A1246 1 HET SO4 A1247 5 HETNAM ZN ZINC ION HETNAM CDP CYTIDINE-5'-DIPHOSPHATE HETNAM CL CHLORIDE ION HETNAM SO4 SULFATE ION FORMUL 2 ZN 2(ZN 2+) FORMUL 4 CDP C9 H15 N3 O11 P2 FORMUL 5 CL 3(CL 1-) FORMUL 8 SO4 O4 S 2- FORMUL 9 HOH *85(H2 O) HELIX 1 1 ASP A 119 GLY A 134 1 16 HELIX 2 2 ASP A 137 PHE A 142 1 6 HELIX 3 3 LYS A 152 LYS A 168 1 17 HELIX 4 4 LYS A 185 ASN A 202 1 18 HELIX 5 5 ASP A 204 SER A 206 5 3 HELIX 6 6 LEU A 218 GLU A 223 1 6 SHEET 1 AA 6 THR A 99 LEU A 102 0 SHEET 2 AA 6 VAL A 105 LEU A 113 -1 O VAL A 105 N LEU A 102 SHEET 3 AA 6 ARG A 65 VAL A 77 -1 O LYS A 74 N LEU A 113 SHEET 4 AA 6 ALA A 226 PRO A 237 -1 O ILE A 227 N HIS A 73 SHEET 5 AA 6 TYR A 170 ILE A 180 -1 O ASP A 171 N ILE A 236 SHEET 6 AA 6 ILE A 208 LYS A 213 1 O SER A 209 N ILE A 177 LINK OD2 ASP A 71 ZN ZN A1240 1555 1555 2.02 LINK NE2 HIS A 73 ZN ZN A1240 1555 1555 2.05 LINK ND1 HIS A 123 ZN ZN A1240 1555 1555 2.06 LINK NE2 HIS A 215 ZN ZN A1241 1555 1555 2.06 LINK OE1 GLU A 228 ZN ZN A1241 2455 1555 2.35 LINK ZN ZN A1240 O HOH A2009 1555 1555 1.82 LINK ZN ZN A1241 CL CL A1244 1555 1555 2.20 LINK ZN ZN A1241 CL CL A1246 1555 1555 2.30 CISPEP 1 VAL A 183 PRO A 184 0 0.83 SITE 1 AC1 5 ASP A 71 HIS A 73 HIS A 123 CDP A1242 SITE 2 AC1 5 HOH A2009 SITE 1 AC2 5 TYR A 70 HIS A 215 GLU A 228 CL A1244 SITE 2 AC2 5 CL A1246 SITE 1 AC3 21 ASP A 137 GLY A 139 THR A 140 ALA A 181 SITE 2 AC3 21 PRO A 184 LYS A 185 ILE A 186 SER A 187 SITE 3 AC3 21 GLY A 212 LYS A 213 THR A 214 GLU A 216 SITE 4 AC3 21 ZN A1240 HOH A2008 HOH A2009 HOH A2010 SITE 5 AC3 21 HOH A2040 HOH A2041 HOH A2081 HOH A2082 SITE 6 AC3 21 HOH A2083 SITE 1 AC4 3 HIS A 215 ILE A 221 ZN A1241 SITE 1 AC5 4 HIS A 73 LYS A 74 LEU A 113 GLU A 216 SITE 1 AC6 3 HIS A 215 GLU A 228 ZN A1241 SITE 1 AC7 4 GLY A 219 VAL A 220 HOH A2077 HOH A2085 CRYST1 84.864 84.864 101.031 90.00 90.00 120.00 H 3 9 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011784 0.006803 0.000000 0.00000 SCALE2 0.000000 0.013606 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009898 0.00000